Davis Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Davis Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$96	Buy	+1	New	+$103	﹤0.01%	1080

Other funds holding LMAT

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Davis Capital Management's LMAT Position: Q2 2026 in Review

Davis Capital Management opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 1 share worth $96. The stake represents ﹤0.01% of the portfolio and ranks #1080 among its holdings.

63 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Davis Capital Management held 1 share of LeMaitre Vascular worth $96 as of Q2 2026.
LeMaitre Vascular was a new Davis Capital Management position in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1080 holding.
63 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.